The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 14th year, is a unique and exciting multidisciplinary program. The Congress is the premiere global meeting dedicated to diabetes, obesity, metabolism, and energy balance, linking research to clinical practice, and highlighting our theme - Exploring New Frontiers in Metabolism - Tomorrow’s Clinical Science Today.
For more than a decade, the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) has brought researchers, physicians, and other clinicians & healthcare professionals together for a distinctive international program that bridges bench to bedside. WCIRDC offers attendees a unique experience, interacting with the distinguished global faculty experiencing a program, which promotes a new understanding of metabolic diseases; facilitate the development of future therapeutic modalities; and implement the management of obesity and diabetes focusing on lifestyle and beyond, evaluating contemporary medications, devices and surgeries to preventing CVD and other complications.
WCIRDC Program Objectives
The program is designed to evaluate both clinical and basic science aspects of diabetes, obesity, and CVD, focusing on insulin resistance, hyperinsulinemia, fat cell, incretins, the gut, the brain, the kidney and energy metabolism. The goal is to understand its pathophysiology, and to develop appropriate comprehensive clinical management plans.
This educational initiative is designed for cardiologists, endocrinologists, diabetologists, internists, family physicians, gastroenterologists, OBGYNs, pediatricians, dieticians, nurse practitioners, pharmacists, and any other health care professional who is interested in insulin resistance, diabetes, obesity, and cardiovascular disease, and multiple metabolic mechanisms’ affect on health and society, as well as on potential treatment and prevention.
You are cordially invited to become an exhibitor of the 14th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC).
The 14th WCIRDC will be held on December 1-3, 2016 in California at the Hilton Universal City hotel.
We offer Exhibit space to expand your company’s appreciation, and to expose your products and services to the nearly 500 health care professionals who attend the annual meeting.
WCIRDC is committed to give exhibitors the best value for their participation.
The WCIRDC is an excellent opportunity to meet with globally-recognized medical leaders, clinicians and scientists who present and share their knowledge. The WCIRDC is designed to evaluate both clinical and basic science aspects of insulin resistance, obesity, diabetes, and CVD.
The WCIRDC achieves a great balance between clinical practice and research, by utilizing a state of the art approach: “Exploring New Frontiers in Metabolism - Tomorrow’s Clinical Science Today!”
The WCIRDC will dedicate an area, separate from the educational program, where your company will be able to exhibit products, equipment and services.